The Wilms' tumor 1 gene: Oncogene or tumor suppressor gene?

International Review of Cytology

Volumn 181, Issue , 1998, Pages 151-212

  Menke, A L ^a,b   Van Der Eb, A J ^a,b   Jochemsen, A G ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Apoptosis; Development; Transcription; Tumorigenesis; Wilms' tumor

Indexed keywords

APOPTOSIS; CARCINOGENESIS; CELL PROLIFERATION; HOMEOSTASIS; HUMAN; KIDNEY CANCER; KIDNEY DEVELOPMENT; NEPHROBLASTOMA; ONCOGENE; PRIORITY JOURNAL; REVIEW; RNA SPLICING; TUMOR SUPPRESSOR GENE;

EID: 0031921306     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7696(08)60418-0     Document Type: Review

References (253)

1. Adachi, Y., Matsubara, S., Pedraza, C, Ozawa, M., Tsutsui, J.-L, Takamatsu, H., Noguchi, H., Akiyama, T., and Muramatsu, T. (1996). Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). Oncogene 13, 2197-2203.
2. Akasaka, Y., Kikuchi, H., Nagai, T., Hiraoka, N., Kalo, S., and Hata, J.-i. (1993). A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitoury abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. FEES Lett. 317, 39-43.
3. Algar, E. M., Kenney, M. T., Simms, L. A., Smith, S. I., Kida, Y., and Smith, P. J. (1995). Homozygous intragenic deletion in the WT1 gene in sporadic Wilms' tumour associated with high levels of expression of a truncated transcript. Hum. Mittat. 5, 221-227.
4. Algar, E. M., Khromykh, T., Smith, S. I., Blackburn, D. M., Bryson, G. J., and Smith, P. J. (1996). A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12, 1005-1014.
5. Amin, K. M., Litzky, L. A., Smythe, W. R., Mooney, A. M., Morris, J. M., Mews, D. J. Y., Pass, H. I., Kari, C, Rodeck, U., Rauscher, F. J., Kaiser, L. R., and Albelda, S. M. (1995). Wilms' Tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am. J. Pathol 146, 344-356.
6. Armstrong, J. F., Pritchard-Jones, K., Bickmore, W. A., Hastie, N. D., and Bard, J. B. L. (1992). The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech. Dev. 40, 85-97.
7. Baird, P. N., and Cowell, J. K. (1993). A novel zinc finger mutation in a patient with Denys-Drash syndrome. Hum. Mol. Genet. 2, 2193-2194.
8. Baird, P. N., Groves, N., Haber, D. A., Housman, D. E., and Cowell, J. K. (1992a). Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene 7, 2141-2149.
9. Baird, P. N., Santos, A., Groves, N., Jadresic, L., and Cowell, J. K. (1992b). Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum. Mol. Genet. 1, 301-305.
10. Bardeesy, N., Zabel, B., Schmitt, K., and Pelletier, J. (1994). WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominantnegative fashion. Genomics 21, 663-665.
11. Bates, R. C, Buret, A., Van Helden, D. F., Horton, M. A., and Burns, G. F. (1994). Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125, 403-415.
12. Beckwith, J. B., Kiviat, N. B., and Bonadio, J. F. (1990). Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr. Pathol. 10, 1-36.
13. Bellamy, C. O. C, Malcomson, R. D. G., Harrison, D. J., and Wyllie, A. (1995). Cell death in health and disease: The biology and regulation of apoptosis. Cancer Biol. 6, 3-16.
14. Benedict, W. F., Weissman, B. E., Mark, C, and Stanbridge, E. J. (1984). Tumorigenicity of human HT1080 fibroblasts x normal fibroblast hybrids is chromosome dosage dependent. Cancer Res. 44, 3471-3479.
15. Bickmore, W. A., Oghene, K., Little, M. H., Seawright, A., van Heyningen, V., and Hastie, N. D. (1992). Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wtl gene transcript. Science 257, 235-237.
16. Bicsak, T. A., Turker, E. M., Cappel, J., Vaughan, J., River, J., Vale, W., and Hsueh, A. J. W. (1986). Hormonal regulation of granulosa cell inhibin biosynthesis. Endocrinology 119, 2711-2719.
17. Birchmeier, C, Meyer, D., and Riethmacher, D. (1995). Factors controlling growth, motility, and morphogenesis of normal and malignant epithelial cells. Int. Rev. Cytol. 160, 221-266.
18. Bowen-Pope, D. F., Van Koppen, A., and Schatteman, G. (1991). Is PDGF really important? Testing the hypotheses. Trends Genet. 7, 413-418.
19. Brenner, B., Wildhardt, G., Schneider, S., and Royer-Pokora, B. (1992). RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors. Oncogene 7, 1431-1433.
20. Brenner, B. M., and Stein, J. H. (1989). "Atrial Natriuretic Peptides." Churchill Livingstone, New York.
21. Breslow, N. E., and Langholz, B. (1983). Childhood-cancer incidence-Geographical and temporal variations. Int. J. Cancer 32, 703-716.
22. Brieger, J., Weidmann, E., Fenchel, K., Mitrou, P. S., Hoelzer, D., and Bergmann, L. (1994). The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 8, 2138-2143.
23. Brown, K. W., Watson, J. E., Poirier, V., Mott, M. G., Berry, P. J., and Maitland, N. J. (1992). Inactivation of the remaining allele of the \VT1 gene in a Wilms' tumour from a WAGR patient. Oncogene 7, 763-768.
24. Brown, K. W., Wilmore, H. P., Watson, J. E., Mott, M. G., Berry, P. J., and Maitland, N. J. (1993). Low frequency of mutations in the WT1 coding region in Wilms' tumor. Genes Chromosomes Cancer 8, 74-79.
25. Bruening, W., and Pelletier, J. (1996). A non-AUG translation initiation event generates novel WT1 isoforms. J. Biol. Chem. 271, 8646-8654.
26. Bruening, W., Bardeesy, N., Silverman, B. L., Cohn, R. A., and Machin, G. A. (1992). Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nature Genet. 1, 144-148.
27. Bruening, W., Gros, P., Sato, T., Stanimir, J., Nakamura, Y., Housman, D., and Pelletier, J. (1993). Analysis of the Ilpl3 Wilms' tumor suppressor gene (WT1) in ovarian tumors. Cancer Invest. 11, 393-399.
28. Buckler, A. J., Pelletier, J., Haber, D. A., Glaser, T., and Housman, D. E. (1991). Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol. Cell. Biol. 11, 1707-1712.
29. Caceres, J. F., Stamm, S., Helman, D., and Krainer, A. (1994). Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 256, 1706-1709.
30. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Krai, A., Yeger, H., Lewis, W. H., Jones, C, and Housman, D. E. (1990). Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60, 509-520.
31. Caricasole, A., Duarte, A., Larsson, S. H., Hastie, N. D., Little, M., Holmes, G., Todorov, I., and Ward, A. (1996). RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc. Natl. Acad. Sci. USA 93, 7562-7566.
32. Chandler, D., EI-Naggar, A. K., Brisbay, S., Redline, R. W., and McDonnel, T. J. (1994). Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: Evidence for the contribution of bcl-2 to renal carcinogenesis. Hum. Palhol. 25, 789-796.
33. Chevalier, R. L., Fern, R. J., Garmey, M., El-Dahr, S. S., Gomez, R. A., and de-Vente, J. (1992). Localization of cyclic GMP following infusion of ANP or nitroprusside in the maturing rat. Am. J. Pliysiol. 262, 417-424.
34. Clarke, M. F., Kukowska-Latallo, J. F., Westin, E., Smith, M., and Prochovnik, E. V. (1988). Constitutive expression of a c-myb cDNA blocks Friend erythroleukemia cell differentiation. Mol. Cell. Biol. 8, 884-892.
35. Clarkson, P. A., Davies, H. R., Williams, D. M., Chaudhary, R., Hughes, I. A., and Patterson, M. N. (1993). Mutational screening of the Wilms' tumour gene, WT1, in males with genital abnormalities. J. Med. Genet. 30, 767-772.
36. Cohen, H. T., Bossone, S. A., Zhu, G., McDonald, G. A., and Sukhatme, V. P. (1997). Spl is a critical regulator of the Wilm' tumor 1 gene. J. Biol. Chem. 272, 2901-2913.
37. Coles, H. S. R., Burne, J. F., and Raff, M. C. (1993). Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118, 777-784.
38. Cook, D. M., Hinkes, M. T., Bernfield, M. and Rauscher, F. J., Ill (1996). Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Oncogene 13, 1789-1799.
39. Coppes, M. J., Liefers, G. J., Higuchi, M., Zinn, A. B., Balfe, J. W., and Williams, B. R. G. (1992). Inherited WT1 mutations in Denys-Drash syndrome. Cancer Res. 52, 6125-6128.
40. Coppes, M. J., Campbell, C. E., and Williams, B. R. G. (1993a). The role of WT1 in tumorigenesis. FASEB J. 7, 886-895.
41. Coppes, M. J., Ye, Y., Rackley, R., Zhao, X.-I., Liefers, G. J., Casey, G., and Williams, B. R. G. (1993b). Analysis of WT1 in granulosa cell and other sex cord-stromal tumors. Cancer Res. 53, 2712-2714.
42. Coppes, M. J., Liefers, G. J., Paul, P., Yeger, H., and Williams, B. R. G. (1993c). Homozygous somatic WT1 point mutations in sporadic unilateral Wilms' tumor. Proc. Natl. Acad. Sci. USA 90, 1416-1419.
43. Cowell, J. K., Wadey, R. B., Haber, D. A., Call, K. M., Housman, D. E., and Pritchard, J. (1991). Structural rearrangements of the WT1 gene in Wilms' tumour cells. Oncogene 6, 595-599.
44. Deb, S. P., Munoz, R. M., Brown, D. R., Subler, M. A., and Deb, S. (1994). Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 9, 1341-1349.
45. Dehbi, M., and Pelletier, J. (1996). Pax-8-mediated activation of the WT1 tumor suppressor gene. EMBO J. 16, 4297-4306.
46. Dehbi, M., Gharemani, M., Lechner, M., Dressler, G., and Pelletier, J. (1996). The pairedbox transcription factor, PAX2, positively modulates expression of the Wilms1 tumor suppressor gene (WT1). Oncogene 13, 447-453.
47. Demetri, G., Zenzie, B., Rheinwald, R., and Griffin, J. (1989). Expression of colony stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cell lines in vitro. Blood 74, 940-946.
48. Denys, P., Malvaux, P., Van den Berghe, H., Tanghe, W., and Proesmans, W. (1967). Association d'un syndrome anatomopathologique de pseudohermaphrodisme masculin, d'une tumeur de Wilms d'une nephropathie parenchymateuse et d'un mosaicisme XX/XY. Arch. Fr. Pediatr. 24, 729-739.
49. Devriendt, K., Deloof, E., Moerman, P., Leguis, E., Vanhole, C., De Zegher, F., Proesmans, W., and Devlieger, H. (1995). Diaphragmatic hernia in Denys-Drash syndrome. Am. J. Med. Genet. 57, 97-101.
50. Dey, B. R., Sukhatme, V. P., Roberts, A. B., Sporn, M. B., Rauscher, F. J., III, and Kim, S.-J. (1994). Repression of the transforming growth factor-/31 gene by the Wilms' tumor suppressor WT1 gene product. Mol. Endocrinol. 8, 595-602.
51. Drash, A., Sherman, F., Hartmann, W. H., and Blizzard, R, M. (1970). A syndrome of pseudohermaphroditisme, Wilms' tumor, hypertension and degenerative renal disease. J. Pediatr. 76, 585-593.
52. Dressler, G. R., and Douglas, E. C. (1992). Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms' tumor. Proc. Natl. Acad. Sci. USA 89, 1179-1183.
53. Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P., and Rauscher, F. J., Ill (1992). Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257, 674-678.
54. Drummond, I. A., Rupprecht, H. D., Rohwer-Nutter, P., Lopez-Guisa, J. M., Madden, S. L., Rauscher, F. J., Ill, and Sukhatme, V. P. (1994). DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol. Cell. Biol. 14, 3800-3809.
55. Eccles, M. R., Grubb, G., Ogawa, O., Szeto, J., and Reeve, A. E. (1994). Cloning of novel Wilms tumor gene (WT1) cDNAs; evidence for antisense transcription of WT1. Oncogens 9, 2059-2063.
56. Englert, C., Vidai, M., Maheswaran, S., Ge, Y., Ezzell, R., Isselbacher, K. J., and Haber, D. A. (1995a). Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc. Natl. Acad. Sci. USA 92, 11960-11964.
57. Englert, C, Hou, X., Maheswaran, S., Bennett, P., Ngwu, C, Re, G. G., Garvin, A. J., Rosner, M. R., and Haber, D. A. (1995b). WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 14, 4662-4675.
58. Evans, G. I., Wyllie, A. H., Gilber, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. (1992). Induction of apoptosis in fibroblasts by cmyc protein. Cell 69, 119-128.
59. Fraizer, G. C, Wu, Y.-J., Hewitt, S. M., Maity, T., Ton, C. C. T., Huff, V., and Saunders, G. F. (1994). Transcriptional regulation of the human wilms tumor gene (WT1). J. Biol. Chem. 269, 8892-8900.
60. Fraizer, G. C, Patmasiriwat, P., Zhang, X., and Saunders, G. F. (1995). Expression of the tumor-suppressor gene WT1 in both human and mouse bone marrow. Blood 86, 4704-4706.
61. Francke, U., Holmes, L. B., Atkins, L., and Riccardi, V. M. (1979). Aniridia-Wilms' tumor association: Evidence for specific deletion llplS. Cylogenet. Cell Genet. 24, 185-192.
62. Frisch, S. M., and Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626.
63. Fu, X.-D., and Maniatis, T. (1990). Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature 343, 437-441.
64. Gashler, A., and Sukhatme, V. P. (1995). Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 8O, 191-224.
65. Gashler, A. L., Bonthron, D. T., Madden, S. L., Rauscher, F. J., Ill, Collins, T., and Sukhatme, V. P. (1992). Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' tumor suppressor WT1. Proc. Natl. Acad. Sci. USA 89, 10984-10988.
66. Gerald, W. L., Gramling, T. S., Sens, D. A., and Garvin, A. J. (1992). Expression of the 11pl3 Wilms' tumor gene, WT1, correlates with histologie category of Wilms' tumor. Am. J. PathoL 140, 1031-1037.
67. Gerald, W. L., Rosai, J., and Ladanyi, M. (1995). Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc. Natl. Acad. Sci. USA 92, 1028-1032.
68. Gessler, M., Konig, A., and Bruns, G. A. (1992). The genomic organization and expression of the WT1 gene. Genomics 12, 807-813.
69. Gessler, M., Konig, A., Moore, J., Qualman, S., Arden, K., Cavenee, W., and Bruns, G. A. P. (1993). Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome. Genes Chromosomes Cancer 7, 131-136.
70. Gessler, M., Konig, A., Arden, K., Grundy, P., Orkin, S., Sallan, S., Peters, C., Ruyle, S., Madell, J., Li, F., Cavenee, W., and Bruns, G. (1994). Infrequent mutation of the WT1 gene in 77 Wilms' tumors. Hum. Mutat. 3, 212-222.
71. Giudice, L. G, Chandrasekher, Y. A., and Cataldo, N. A. (1993). The potential roles of jntraovarian peptides in normal and abnormal mechanisms of reproductive physiology. Clirr. Opin. Obstet. Gynecol. 5, 350-359.
72. Goodyer, P., Dehbi, M., Torban, E., Bruening, W., and Pelletier, J. (1995). Repression of the retinoic acid receptor-or gene by the Wilms' tumor suppressor gene product, WT1. Oncogcne 10, 1125-1129.
73. Gotloib, L., and Shostak, A. (1995). Endocytosis and transcytosis of albumin gold through mice peritoneal mesothelium. Kidney Int. 47, 1274-1284.
74. Grubb, G. R., Yun, K., Williams, B. R. G., Eccles, M. R., and Reeve, A. E. (1994). Expression of the WT1 protein in fetal kidneys and Wilms tumors. Lab. Invest. 71, 472-479.
75. Grubb, G. R., Yun, K., Reeve, A. E., and Eccles, M. R. (1995). Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour. Oncogene 10, 1677-1681.
76. Guraya, S. S. (1995). The comparative cell biology of accessory somatic (or Sertoli) cells in animal testis. Int. Rev. Cytol. 160, 163-220.
77. Guyton, A. C. (1986). The body fluids and kidneys. In "Textbook of Medical Physiology" pp. 348-463. Saunders, Philadelphia.
78. Haber, D. A., Buckler, A. J., Glaser, T., Call, K. M., Pelletier, J., Sohn, R. L., Douglass, E. G, and Housman, D. E. (1990). An internal deletion within an Ilpl3 zinc finger gene contributes to the development of Wilms' tumor. Cell 61, 1257-1269.
79. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., and Housman, D. E. (1991). Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natt. Acad. Sci. USA 88, 9618-9622.
80. Haber, D. A., Park, S., Maheswara S., Englert, G, Re, G. G., Hazen-Martin, D. J., Sens, D. A., and Garvin, A. J. (1993). WTl-mediated growth suppression of Wilms' tumor cells expressing a WT1 splice variant. Science 262, 2057-2059.
81. Hamilton, T. B., Barilla, K. G, and Romaniuk, P. J. (1995). High affinity binding sites for the Wilms' tumour suppressor protein WT1. Nucleic Acids Res. 23, 277-284.
82. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. (1994). c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13, 3286-3295.
83. Harrington, M. A., Konicek, B., Song, A., Xia, X.-L, Fredericks, W. J., and Rauscher, F. J., Ill (1993). Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem. 268, 21271-21275.
84. Haselbacher, G. K., Irminger, J.-G, Zapf, J., Ziegler, W. H., and Humbel, R. E. (1987). Insulin-like growth factor-II in human adrenal pheochromocytomas and Wilms' tumors: Expression at the messenger-RNA and protein level. Proc. Natl. Acad. Sci. USA 84, 1104-1106.
85. Hastie, N. D. (1994). The genetics of Wilms' tumor-A case of disrupted development. Anmi. Rev. Genet. 28, 523-558.
86. Herzlinger, D., Qiao, J., Cohen, D., Ramakrishna, N., and Brown, A. M. G (1994). Induction of kidney epithelial morphogenesis by cells expressing Wnt-1. Dev. Biol. 166, 815-818.
87. Hewitt, S. M., Hamada, S., McDonnell, T. J., Rauscher, F. J., Ill, and Saunders, G. F. (1995a). Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res. 55, 5386-5389.
88. Hewitt, S. M., Fraizer, G. G, and Saunders, G. F. (1995b). Transcriptional silencer of the Wilms' tumor gene WT1 contains an alu repeat. J. Biol. Chem. 270, 17908-17912.
89. Hewitt, S. M., Fraizer, G. G, Wu, Y. J., Rauscher, F. J., Ill, and Saunders, G. F. (1996).
90. Differential function of the Wilms' tumor gene WT1 splice isoforms in transcriptional regulation. J. Biol. Chem. 271, 8588-8592.
91. Hoffman, B., and Liebermann, D. A. (1994). Molecular controls of apoptosis: Differentiation/growth arrest primary response genes, proto-oncogenes and tumor suppressor genes as positive and negative modulators. Oncogene 9, 1807-1812.
92. Hoffman-Liebermann, B., and Liebermann, D. A. (1991). Interleukin-6 and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemic cells is blocked at an intermediate stage by constitutive c-myc. Mol. Cell. Biol. 11, 2375-2381.
93. Hofmann, W., Royer, H.-D., Drechsler, M., Schneider, S., and Royer-Pokora, B. (1993). Characterization of the transcriptional regulatory region of the human WT1 gene. Oncogens 8. 3123-3132.
94. Hsu, S. Y., Kubo, M., Chun, S.-Y., Haluska, F. G., Housman, D. E., and Hsueh, A. J. W. (1995). Wilms' tumor protein WT1 as an ovarian transcription factor: Decreases in expression during follicle development and repression of inhibin-a gene promoter. Mol. Endocrinol. 9. 1356-1366.
95. Hsueh, A. J. W., Billig, IL, and Tsafriri, A. (1994). Ovarian follicle atresia: A hormonally controlled apoptotic process. Endocr. Rev. IS, 1-18.
96. Huang, A., Campbell, C. E., Bonetta, L., McAndrews-Hill, M.S., Chilton-MacNeill, S., Coppes, M. J., Law, D. J., Feinberg, A. P., Yeger, H., and Williams, B. R. (1990). Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms' tumor. Science 250, 991-994.
97. Huff, V., and Saunders, G. F. (1993). Wilms tumor genes. Biocliim. Biophys. Acta 1155, 295-306.
98. Huff, V., Miwa, H., Haber, D. A., Call, K. M., Housman, D., Strong, L. C, and Saunders, G. F. (1991). Evidence for WT1 as a Wilms tumor ( WT1) gene: Intragenic germinal deletion in bilateral WT. Am. J. Hum. Genet. 48, 997-1003.
99. Ikeda, Y., Shen, W. H., Ingraham, H. A., and Parker, K. L. (1994). Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 8, 654-662.
100. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K., Kyo, T., Dohy, H., Nakauchi, H., Ishidate, T., Akiyama, T., and Kishimoto, T. (1994). WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 8-4, 3071-3079.
101. Jadresic, L., Leake, J., Gordon, I., Dillon, M. J., Grant, D. B., Pritchard, J., Risdon, R. A., and Barrat, T. M. (1990). Clinicopathologic review of twelve children with nephropathy, Wilms' tumor, and genital abnormalities (Drash syndrome). J. Pediatr. 117, 717-725.
102. Jinno, Y., Yun, K., Nishiwaki, K., Kubota, T., Ogawa, O., Reeve, A. E., and Niikawa, N. (1994). Mosaic and polymorphic imprinting of the WT1 gene in humans. Nature Genet. 6, 305-309.
103. Johnson, A. L., and Tilly, J. L. (1994). Expression of bcl-x protooncogene mRNA in granulosa cells during ovarian follicular development. Biol. Reprod. (Suppl. 1) 50, 93.
104. Johnson, A. L., Li, Z., and Tilly, J. L. (1993). Expression of c-myc and bcl-2 mRNA during ovarian follicle development. Biol. Reprod. (Suppl. 1) 48, 152.
105. Johnstone, R. W., See, R. H., Sells, S. F., Wang, J., Muthukkumar, S., Englert, C., Haber, D. A., Licht, J. D., Sugrue, S. P., Roberts, T., Rangnekar, V. M., and Shi, Y. (1996). A novel reppressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol. Cell. Biol. 16, 6945-6956.
106. Junqueira, L. C., and Carneiro, J. (1984). "Functionele Histologie." Wetenschappenlijke Uitgeverij Bunge, Utrecht.
107. Karnieli, E., Werner, H., Rauscher, F. J., Ill, Benjamin, L. E., and LeRoith, D. (1996). The IGF-I receptor gene promoter is a molecular target for Ewing's sarcoma-Wilms' tumor 1 fusion protein. J. Biol. Chem. 271, 19304-19309.
108. Keller, S. A., Jones, J. M., Boyle, A., Barrow, L. L., Killen, P. D., Green, D. G., Kapousta, N. V., Hitchcock, P. F., Swant, R. T., and Meisler, M. H. (1994). Kidney and retinal defects (krd), a transgene-induced mutation with a deletion of mouse chromosome 19 that includes the Pax2 locus. Genomics 23, 309-320.
109. Kennedy, D., Ramsdale, T., Mattick, J., and Little, M. (1996). An RNA recognition motif in Wilms' tumour protein (\VT1) revealed by structural modelling. Nature Genet. 12, 329-332.
110. Kent, J., Coriat, A.-M., Sharpe, P. T., Hastie, N. D., and Van Heyningen, V. (1995). The evolution of WT1 sequence and expression pattern in the vertebrates. Oncogene 11,17811792.
111. Kerr, J- F. R., Winterford, C. M., and Harmon, B. V. (1994). Apoptosis. Its significance in cancer and cancer therapy. Cancer 73, 2013-2026.
112. Khachigian, L. M., Williams, A. J., and Collins, T. (1995). Interplay of Spl and Egr-1 in the proximal platelet-derived-growth-factor-A-chain promoter in cultured vascular endothelial cells. J. Biol. Chem. 270, 27679-27686.
113. Kikuchi, H., Akasaka, Y., Nagai, T., Umezawa, A., Iri, H., Kalo, S., and Hata, J. (1992). Genomic changes in the WT-gene (WT1) in Wilms' tumors and their correlation with histology. Am. J. Pathol. 140, 781-786.
114. Kinane, T. B., Finder, J. D., Kawashima, A., Brown, D., Abbate, M., Fredericks, W. J., Sukhatme, V. P., Rauscher, F. J., II, and Ercolani, L. (1996). LLC-PK1 cell growth is repressed by WT1 inhibition of G-protein a,.2 protooncogene transcription. J. Biol. Chem. 271, 30760-30764.
115. King-Underwood, L., Renshaw, J., and Pritchard Jones, K. (1996). Mutations in the Wilms' tumor gene WT1 in leukemias. Blood 87, 2171-2179.
116. Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C, Lubbert, H., and Bujard, H. (1996). Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 10933-10938.
117. Knudson, A. G., and Strong, L. C. (1972). Mutation and cancer: A model for Wilms' tumor of kidney. J. Nail. Cancer Insl. 48, 313-324.
118. Köng, A., Jakubiczka, S., Wieacker, P., Schlösser, H. W., and Gessler, M. (1993). Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome. Hum. Mol. Genet. 2, 1967-1968.
119. Koseki, C, Herzlinger, D., and AI-Awqati, Q. (1992). Apoptosis in metanephric development. J. Cell Biol. 119, 1327-1333.
120. Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. (1993). WT-1 is required for early kidney development. Cell 74, 679-691.
121. Kudoh, T., Ishidate, T., Moriyama, M., Toyoshima, K., and Akiyama, T. (1995). Gl phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/cdk complexes. Proc. Natl. Acad. Sci. USA 92, 4517-4521.
122. Lamb, D. J. (1995). Genes involved in testicular development and function. World J. Urol. 13, 277-284.
123. Langerak, A. W., Williamson, K. A., Miyagawa, K., Hagemeijer, A. Versnel, M. A., and Hastie, N. D. (1995). Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and the relationship to platelet-derived growth factor A and insulinlike growth factor 2 expression. Genes Chromosomes Cancer 12, 87-96.
124. Larsson, S. H., Charlieu, J. P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V., and Hastie, N. D. (1995). Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81, 391-401.
125. Lewis, W. H., Yeger, H., Bonetta, L., Chan, H. S. L., Kang, J., Junien, C, Cowell, J., Jones, C., and Dafoe, L. A. (1988). Homozygous deletion of a DNA marker from chromosome Ilpl3 in sporadic Wilms' tumor. Genomics 3, 25-31.
126. Li, L., Zhou, J., James, G., Heller-Harrison, R., Cxech, M. P., and Olson, E. N. (1992). FGF activates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA binding domains. Cell 71, 1181-1194.
127. Lin, J.-K., and Chou, C.-K. (1992). In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res. 52, 385-388.
128. Little, M. H., Dunn, R., Byrne, J. A., Seawright, A., Smith, P. J., Pritchard-Jones, K. (1992a). Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours. Oncogens 7, 635-641.
129. Little, M. H., Prosser, J., Condie, A., Smith, P. J., Van Heyningen, V., and Hastie, N. D. (1992b). Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc. Nail. Acati. Sci. USA 89, 4791-4795.
130. Liu, J.-P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstradiadis, A. (1993a). Mice encoding null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell 75, 59-72.
131. Liu, Z. Z., Wada, J., Alvares, K., Kumar, A., Wallner, E. I., and Kanwar, Y. S. (1993b). Distribution and relevance of insulin-like growth factor-I receptor in metanephric development. Kidney Int. 44,1242-1250.
132. Luo, X., Ikeda, Y., and Parker, K. L. (1994). A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77, 481-490.
133. Luo, X.-N., Reddy, J. C, Yeyati, P. L., Idris, A. H., Hosono, S., Haber, D. A., Licht, J. D., and Atweh, G. F. (1995). The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene 11, 743-750.
134. Machin, G. A. (1984). Persistent renal blastema as a precursor of Wilms' tumor. In "Wilms' Tumor: Clinical and Biological Manifestations" (C. Pochedly and E. S. Baum, eds.), pp. 215-250. Elsevier, New York.
135. Madden, S. L., Cook, D. M., Morris, J. F., Gashler, A., Sukhatme, V. P., and Rauscher, F. J., Ill (1991). Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 253, 1550-1553.
136. Madden, S. L., Cook, D. M., and Rauscher, F. J., III (1993). A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. Oncogene 8, 1713-1720.
137. Maheswaran, S., Park, S., Bernard, A., Morris, J. F., Rauscher, F. J., Hill, D. E., and Haber, D. A. (1993). Physical and functional interaction between WT1 and p53 proteins. Proc. Natl. Acad. Sci. USA 90, 5100-5104.
138. Maheswaran, S., Englert, C., Bennett, P., Heinrich, G., and Haber, D. A. (1995). The WT1 gene product stabilizes p53 and inhibits p53 mediated apoptosis. Genes Dev. 9,2143-2156.
139. Malik, K. T. A., Poirier, V., Ivins, S. M., and Brown, K. W. (1994). Autoregulation of the human WT1 gene promoter. FEBS Lett. 349, 75-78.
140. Malik, K. T. A., Wallace, J. I., Ivins, S. M., and Brown, K. W. (1995). Identification of an antisense WT1 promoter in intron 1: Implications for WT1 gene regulation. Oncogene 11, 1589-1595.
141. Mannens, M., Hoovers, J. M., Bleeker-Wagemakers, E. M., Redeker, E., Bliek, J., Overbeeke-Melkert, M., Saunders, G. Williams, B., Van Heyningen, V., Junien, C., Haber, D., Speleman, F., Heyting, C, Slater, R. M., Leschot, N. J., and Westerveld, A. (1991). The distal region of Ilpl3 and associated genetic diseases. Genomics 11, 284-293.
142. Martinerie, C, Chevalier, G., Rauscher, F. J., Ill, and Perbal, B. (1996). Regulation of nov by WT1: A potential role for nov in nephrogenesis. Oncogene 12, 1479-1492.
143. Matsunaga, E. (1981). Genetics of Wilms' tumor. Hum. Genet. 57, 231-246.
144. McCann, S., Sullivan, J., Guerra, J., Arcinas, M., and Boxer, L. M. (1995). Repression of the c-myb gene by \VT1 protein in T and B cell lines. J. Biol. Chem. 270, 23785-23789.
145. McMaster, M. L., Gessler, M., Stanbridge, E. J., and Weissman, B. E. (1995). WT1 expression alters tumorigenicity of the G401 kidney derived cell line. Cell Growth Differ. 6,1609-1617.
146. Menke, A. L., Van Ham, R. C. A., Sonneveld, E., Shvarts, A., Stanbridge, E. J., Miyagawa, K., Van der Eb, A. J., and Jochemsen, A. G. (1995). Human chromosome 11 suppresses the tumorigenicity of adenovirus transformed baby rat kidney cells: Involvement of the Wilms' tumor 1 gene. Int. J. Cancer 63, 76-85.
147. Menke, A. L., Riteco, N., Van Ham, R. C. A., De Bruyne, C, Rauscher, F. J., Ill, Van der Eb, A. J., and Jochemsen, A. G. (1996). Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Oncogens 12, 537-546.
148. Menke, A. L., Shvarts, A., Riteco, N., Van Ham, R. C. A., Van der Eb, A. J., and Jochemsen, A. G. (1997). Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res. 57, 1353-1363.
149. Menssen, H. D., Renkl, H. J., Rodeck, U., Maurer, J., Notier, M., Schwanz, S., Reinhardt, R., and Thiel, E. (1995). Presence of Wilms' tumor gene (WT1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9, 1060-1067.
150. Menssen, H. D., Renkl, H. J., Rodeck, U., Kari, C, Schwartz, S., and Thiel, E. (1997). Detection by monclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemia. Int. J. Cancer 70, 518-523.
151. Mhva, H., Beran, M., and Saunders, G. F. (1992). Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6, 405-409.
152. Miyagawa, K., Kent, J., Schedl, A., Van Heyningen, V., and Hastie, N. D. (1994). Wilms' tumour-A case of disrupted development. J. Cell Sci. Sitppl. 18, 1-5.
153. Miyagi, T., Ahuja, H., Kubota, T., Kubonishi, I., Koeffler, H. P., and Miyoshi, I. (1993). Expression of the candidate Wilms' tumor gene, WT1, in human leukemia cells. Leukemia 7, 970-977.
154. Miyashita, T., and Reed, J. C. (1992). Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52, 5407-5411.
155. Miyashita, T., and Reed, J. C. (1993). Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81, 151-157.
156. Morris, J. F., Madden, S. L., Tournay, O. E., Cook, D. M., Sukhatme, V. P., and Rauscher, F. J. (1991). Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 6, 2339-2348.
157. Moshier, J. A., Skunca, M., Wu, W., Boppana, S. M., Rauscher, F. J., Ill, and Dosescu, J. (1996). Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. Nucleic Acids Res. 24, 1149-1157.
158. Mosialos, G., Hamer, P., Capobianco, A. J., Laursen, R. A., and Gilmore, T. D. (1991). A protein kinase-A recognition sequence is structurally linked to transformation by 59v-rel and cytoplasmic retention of p68c-rel. Mol. Cell. Biol. 11, 5867-5877.
159. Moxham, C. M., Hod, Y., and Malbon, C. C. (1993). Gi alpha 2 mediates the inhibitory regulation of adenylcyclase in vivo: Analysis in transgenic mice with Gi alpha suppressed by inducible antisense RNA. Dev. Genet. 14, 266-273.
160. Mugrauer, G., and Ekblom, P. (1991). Contrasting expression patterns of three members of the myc family of protooncogenes in the developing and adult mouse kidney. J. Cell Biol. 112, 13-25.
161. Mundel, P., and Kriz, W. (1995). Structure and function of podocytes: An update. Anat. Embryol. 192, 385-397.
162. Nakagama, H., Heinrich, G., Pelletier, J., and Housman, D. E. (1995). Sequence and structural requirements for high-affinity DNA-binding by the WT1 gene product. Mol. Cell. Biol. 15,1489-1498.
163. Nakayama, K., Nakayama, K.-L, Negishi, I., Kuida, K., Sawa, H., and Loh, D. Y. (1994). Targeted disruption of Bcl-2ab in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 91, 3700-3704.
164. Nichols, K. E., Re, G. G., Yan, Y. X., Garvin, A. J., and Haber, D. A. (1995). WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells. Cancer Res. 55,4540-4543.
165. Nordenskjold, A., Friedman, E., and Anvret, M. (1994). WT1 mutations in patients with Denys-Drash syndrome: A novel mutation in exon 8 and paternal allele origin. Hum. Genet. 93, 115-120.
166. Nyman, U., Hallman, H., Hadlaczky, G., Petterson, I., Sharp, G., and Ringertz, N. (1986). Intranuclear localization of SnRNP antigens. J. Cell Biol. 102, 137-144.
167. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor. Proc. Natl. Acad. Sci. USA 89,5408-5412.
168. Ogawa, O., Eccles, M. R., Yun, K., Mueller, R. F., Holdaway, M. D. D., and Reeve, A. E. (1993). A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. Hum. Mol. Genet. 2, 203-204.
169. Paik, S., Rosen, N., Jung, W., You, J. M., Lippman, M. E., Perdue, J. F., and Yee, D. (1989). Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. Lab. Invest. 61, 522-526.
170. Park, S., Schalling, M., Bernard, A., Maheswaran, S., Shipley, G. C, Roberts, D., Fletcher, J., Shipman, R., Rheinwald, J., Demetri, G., Griffin, J., Minden, M., Housman, D. E., and Haber, D. A. (1993a). The Wilms tumour gene \VT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genet. 4, 415-420.
171. Park, S., Tomlinson, G., Nisen, P., and Haber, D. A. (1993b). Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor. Cancer Res. 53, 4757-4760.
172. Parr, M. B., Tung, H. N., and Parr, E. L. (19S6). The ultrastructure of the rat primary decidual zone. Am. J. Anal. 176, 423-436.
173. Pavletich, N. P., and Pabo, C. O. (1991). Zinc finger-DNA recognition: Crystal structure of a ZIF268-DNA complex at 2.1A. Science 252, 809-817.
174. Pelletier, J., Bruening, W., Kashtan, C. E., Mauer, S. M., Manivel, J. C, Striegel, J. E., Houghton, D. C, Junien, C., Habib, R., Fouser, L., Fine, R. N., Silverman, B. L., Haber, D. A., and Housman, D. (1991a). Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67, 437-447.
175. Pelletier, J., Schalling, M., Buckler, A., Rogers, A., Haber, D. A., and Housman, D. (1991b). Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 5, 1345-1356.
176. Pelletier, J., Bruening, W., Li, F. P., Haber, D. A., Glaser, T., and Housman, D. E. (1991c). WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 353, 431-434.
177. Phelan, S. A., Linberg, C, and Call, K. M. (1994). Wilms' tumor gene, WT1, mRNA is downregulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ. 5, 677-686.
178. Ponchel, F., Puisieux, A., Tabone, E., Michot, J. P., Froschl, G., Morel, A. P., Frebourg, T., Fontaniere, B., Oberhammer, F., and Ozturk, M. (1994). Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor β1-mediated apoptosis. Cancer Res. 54, 2064-2068.
179. Poulat, F., Morin, D., Konig, A., Brun, P., Giltay, J., Sultan, C., Dumas, R., Gessler, M., and Berta, P. (1993). Distinct molecular origins for Denys-Drash and Frasier syndromes. Hum. Genet. 91, 285-286.
180. Pritchard-Jones, K., and Flemming, S. (1991). Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: Implications for tumour histogenesis. Oncogene 6, 2211-2220.
181. Pritchard-Jones, K., Flemming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., Van Heyningen, V., and Hastie, N. (1990). The candidate Wilms' tumour gene is involved in genitoury development. Nature 346, 194-197.
182. Rackley, R. R., Flenniken, A. M., Kuriyan, N. P., Kessler, P. M., Stoler, M. H., and Williams, B. R- G. (1993). Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis. Cell Growth Differ. 4, 1023-1031.
183. Radice, P., Pilotti, S., De Benedetti, V., Mondini, P., Miozzo, M., Luksch, R., Fossati Bellani, F., Delia Porta, G., and Pierotti, M. A. (1993). Homozygous intragenic loss of the WT1 locus in a sporadic intralobular Wilms' tumor. Int. J. Cancer 55, 174-176.
184. Rahman, N., Arbour, L., Tonin, P., Renshaw, J., Pelletier, J., Baruchel, S., Prithard-Jones, K., Stratton, M. R., and Narod, S. A. (1996). Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17ql2-q21. Nature Genet. 13, 461-463.
185. Rassoulzadegan, M., Paquis-Flucklinger, V., Bertino, B., Sage, J., Jasin, M., Miyagawa, K., Van Heyningen, V., Besmer, P, and Cuzin, F. (1993). Transmeiotic differentiation of male germ cells in culture. Cell 75, 997-1006.
186. Rauscher, F. J., Morris, J. F., Tournay, O. E., Cook, D. M., and Curran, T. (1990). Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250, 1259-1262.
187. Rauscher, F. J.,(1993). The WT1 Wilms tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 7,896-903.
188. Reddy, J. C, and Licht, J. D. (1996). The WT1 Wilms' tumor suppressor gene: How much do we really know? Biochim. Biopliys. Acta 1287, 1-28.
189. Reddy, J. C, Morris, J. C, Wang, J., English, M. A., Haber, D. A., Shi, Y., and Licht, J. D. (1995a). WTl-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J. Biol. Chem. 270, 10S78-10884.
190. Reddy, J. C, Hosono, S., and Licht, J. D. (1995b). The transcriptional effect of WT1 is modulated by choice of expression vector. J. Biol. Chem. 270, 29976-29982.
191. Reeve, A. E., Eccles, M. R., Wilkins, R. J., Bell, G. I., and Millow, L. J. (1985). Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317, 258-260.
192. Resnicoff, M., Burgaud, J.-L., Rotman, H. L., Abraham, D., and Baserga, R. (1995). Correlation between apoptosis, tumorigenesis, and levels of insuline growth factor I receptors. Cancer Res. 55, 3739-3741.
193. Rihs, H. P., Jans, D. A., Fan, H., and Peters, R. (1991). The rate of nuclear cytoplasmic protein transport is determined by the casein kinase II site flanking the nuclear localization sequence of the SV40 T-antigen. EMBO J. 10, 633-639.
194. Rodeck, U., Bossier, A., Kari, C, Humphreys, C. W., Gyorfi, T., Maurer, J., Thiel, E., and Menssen, H. D. (1994). Expression of the WT1 Wilms' tumor gene by normal and malignant melanocytes. Int. J. Cancer 59, 78-82.
195. Roth, P., and Stanley, E. K. (1992). The biology of CSF-1 and its receptor. Curr. Top. Microbiol. Immunol. 181, 141-167.
196. Rothenspieler, U. W., and Dressier, G. R. (1993). Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development 119, 711-720.
197. Royer-Pokora, B., Ragg, S., Heckl-Ostreicher, B., Held, M., Loos, U., Call, K., Glaser, T., Housman, D., Saunders, G., Zabel, B., Wiliams, B., and Poustka, A. (1991). Direct pulsed field gel electrophoresis of Wilms tumors shows that DNA deletions in Ilpl3 are rare. Genes Chromosomes Cancer 3, 89-100.
198. Rupprecht, H. D., Drummond, I. A., Madden, S. L., Rauscher, F. J., and Sukhatme, V. P. (1994). The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J. Biol. Chem. 269, 6198-6206.
199. Ryan, G., Steele-Perkins, V., Morris, J. F., Rauscher, F. J., III, and Dressler, G. R. (1995). Repression of Pax-2 by WT1 during normal kidney development. Development 121,867-875.
200. Sakai, A., Tadokoro, K., Yanagisawa, H., Nagafuchi, S., Hoshikawa, N., Suzuki, T., Koshaka, T., Hasegawa, T., Nakahori, Y., and Yamada, M. (1993). A novel mutation of the WT1 gene (a tumour suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome. Hum. Mol. Genet. 2, 1969-1970.
201. Sakamuro, D., Eviner, V., Elliot, K. J., Showe, L., White, E., and Prendergast, G. C. (1995). c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11, 2411-2418.
202. Santos, A., Osorio-Almeida, L., Baird, P. N., Suva, J. M., Boavida, M. G., and Cowell, J. (1993). Insertional inactivation of the WT1 gene in tumour cells from a patient with the WAGR syndrome. Hum. Genet. 92, 83-86.
203. Scharnhorst, V., Kranenburg, O., Van der Eb, A. J., and Jochemsen, A. G. (1997). Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells. Cell Growth Differ. 8, 133-143.
204. Schlafke, S., Welsh, A. O., and Enders, A. C. (1985). Penetration of the basal lamina of the uterine luminel epithelium during implantation in the rat. Anat. Rec. 212, 47-56.
205. Schneider, S., Wildhardt, G., Ludwig, R., and Royer-Pokora, B. (1993). Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations. Hum. Genet. 91, 599-604.
206. Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Constantin!, F., and Pachnis, V. (1994). Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor ret. Nature 367, 380-383.
207. Scott, J., Cowell, J., Robertson, M. E., Priestley, L. M., Wadey, R., Hopkins, B., Pritchard, J., Bell, G. I., Rail, L. B., Graham, C. F., and Knott, T. J. (1985). Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature 317, 260-262.
208. Sekiya, M., Adachi, M., Hinoda, Y., Imai, K., and Yachi, A. (1994). Downregulation of Wilms' tumor 1 gene (WT1) during myelomonocytic differentiation in HL60 cells. Blood 83, 1876-1882.
209. Selvakumaran, M., Lin, H. K., Sjin, R. T., Reed, J. C, Liebermann, D. A., and Huffman, B. (1994). The novel primary response gene MyDllS and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. Mol. Cell. Biol. 14, 2352-2360.
210. Sen, S. (1992). Programmed cell death: Concept, mechanism and control. Biol. Rev. 67, 287-319.
211. Seufert, W., Futcher, B., and Jentsch, S. (1995). Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373, 78-81.
212. Sharma, P. M., Yang, X., Bowman, M., Roberts, V., and Sukumar, S. (1992). Molecular cloning of rat Wilms' tumor complementary DNA and study of messenger RNA expression in the urogenital system and the brain. Cancer Res. 52, 6407-6412.
213. Sharma, P. M., Bowman, M., Yu, B.-F., and Sukumar, S. (1994a). A rodent model for Wilms tumors: Embryonal kidney neoplasms induced by N-nitroso-N'-methylurea. Proc. Nail. Acad. Sci. USA 91, 9931-9935.
214. Sharma, P. M., Bowman, M., Madden, S. L., Rauscher, F. J., and Sukumar, S. (1994b). RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes Dev. 8, 720-731.
215. Sharpe, C. R., and Franco, E. L. (1995). Etiology of Wilms' tumor. Epidemiol. Rev. 17,415-432.
216. Shen, W. H., Moore, C. C, Ikeda, Y., Parker, K. L., and Ingraham, H. A. (1994). Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: A link to the sex determination cascade. Cell 77, 651-661.
217. Simms, L. A., Algar, E. M., and Smith, P. J. (1995). Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour. Eur. J. Cancer 31, 2270-2276.
218. Slater, R. M., and Mannens, M. M. A. M. (1992). Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet. Cytogenet. 61, 111-121.
219. Sorenson, C. M., Rogers, S. A., Korsmeyer, S. J., and Hammerman, M. R. (1995). Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am. J. Physiol. 268, 73-81.
220. Spector, D. (1993). Macromolecular domains within the cell nucleus. Annu. Rev. Cell Biol. 9, 265-315.
221. Spector, D., Fu, X.-D., and Maniatis, T. (1991). Associations between distinct pre-mRNA splicing components and the cell nucleus. EMBO J. 10, 3467-3481.
222. Stark, K., Vanio, S., Vassileva, G., and McMahon, A. P. (1994). Wnt-4 regulates epithelial transformation of metanephric mesenchyme in the developing kidney. Nature 372,679-683.
223. Tadokoro, K., Fujii, H., Oshima, A., Kakizawa, Y., Shimizu, K., Sakai, A., Sumiyoshi, K., Inoue, T., Hayashi, Y., and Yamada, M. (1992). Intragenic homozygous deletion of the WT1 gene in Wilms' tumor. Oncogens 7, 1215-1221.
224. Telerman, A., Dodemont, H., Degraef, C, Galand, P., Bauwens, S., Van Oostveldt, P., and Amson, R. B. (1992). Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene. Oncogens 7, 2545-2548.
225. Tilly, J- L- B'Hig. H., Kowalski, K. I., and Hsueh, A. J. W. (1992). Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol. Endocrinol. 6, 1942-1950.
226. Tilly, K. I., Banerjee, S., Banerjee, P. P., and Tilly, J. L. (1995). Expression of the p53 and Wilms' tumor suppressor genes in the rat ovary: Gonadotropin repression in vivo and immunochemical localization of nuclear p53 protein to apoptotic granulosa cells of atretic follicles. Endocrinology 136, 1394-1402.
227. Tsuda, M., Sakiyama, T., Kitagawa, T., Watanabe, S., Watanabe, T., Takahashi, S., Kawaguchi, H., and Ito, K. (1993). Molecular analysis of two Japanese cases of Denys-Drash syndrome. J. Inker. Metab. Dis. 16, 876-880.
228. Van Heyningen, V., and Hastie, N. D. (1992). Wilms' tumour: Reconciling genetics and biology. Trends Genet. 8, 16-21.
229. Van Heyningen, V., Bickmore, W. A., Seawright, A., Fletcher, J. M., Maule, J., Fekete, G., Gessler, M., Bruns, G. A. P., Huerre-Jeanpierre, C. Junien, C, Williams, B. R. G., and Hastie, N. D. (1990). Role for the Wilms tumor gene in genital development? Proc. Natl. Acad. Sei USA 87, 5383-5386.
230. Varanasi, R., Bardeesy, N., Ghahremani, M., Petruzzi, M.-J., Nowak, N., Adam, M. A., Grundy, P., Shows, T. B., and Pelletier, J. (1994). Fine structure analysis of the WT1 gene in sporadic Wilms' tumors. Proc. Nail. Acad. Sci. USA 91, 3554-3558.
231. Vaux, D. L., Cory, S., and Adams, J. M. (1988). BcI-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 355, 440-442.
232. Veis, D. J., Sorenson, C. M., Shutter, J. R., and Korsmeyer, S. J. (1993). Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240.
233. Waber, P. G., Chen, J., and Nisen, P. D. (1993). Infrequency of ras, p53, WT1, or Rb gene alterations in Wilms' tumor. Cancer 72, 3732-3738.
234. Walker, C, Rutten, F., Yuan, X., Pass, H., Mew, D. M., and Everitt, J. (1994). Wilms' tumor suppressor gene expression in rat and human mesothelioma. Cancer Res. 54, 3101-3106.
235. Wang, Z., Qiu, Q., Huang, J., Gurrieri, M., and Deuel, T. F. (1995a). Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, WT1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene 10, 415-422.
236. Wang, Z., Qiu, Q., Gurrieri, M., Huang, J., and Deuel, T. F. (1995b). WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene 10, 1243-1247.
237. Wang, Z. Y., Madden, S. L., Deuel, T. F., and Rauscher, F. J., III (1992). The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J. Biol. Chem. 267, 21999-22002.
238. Wang, Z.-Y., Qiu, Q.-Q., and Deuel, T. F. (1993a). The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J. Biol. Chem. 268, 9172-9175.
239. Wang, Z.-Y., Qiu, Q.-Q., Enger, K. T., and Deuel, T. (1993b). A second transcriptionally active DNA-binding site for Wilms tumor gene product, WT1. Proc. Natl. Acad. Sci. USA 90, 8896-8900.
240. Wang, Z.-Y., Qiu, Q.-Q., Seufert, W., Taguchi, T., Testa, J. R., Whitmore, S. A., Callen, D. F., Welsh, D., Shenk, T., and Deuel, T. F. (1996). Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9. J. Biol. Cliem. 271,24811-24816.
241. Ward, A., Pooler, J. A., Miyagawa, K., Duarte, A., Hastie, N. D., and Caricasole, A. (1995). Repression of promoters for the mouse insulin-like growth-factor II-encoding gene (IGF2) by products of the Wilms' tumour suppressor gene WT1. Gene 167, 239-243.
242. Welsh, A. O., and Enders, A. C. (1985). Light and electron microscopic examination of the mature decidual cells of the rat with emphasis on the antimesometrial decidua and its degeneration. Am. J. Anat. 172, 1-29.
243. Werner, H., Re, G. G., Drummond, I. A., Sukhatme, V. P., Rauscher, F. J., Sens, D. A., Garvin, A. J., LeRoith, D., and Roberts, C. T. Jr. (1993). Increased expression of the insulinlike growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc. Natl. Acad. Sci. USA 90, 5828-5832.
244. Werner, H., Rauscher, F. J., Sukhatme, V. P., Drummond, I. A., Roberts, C. T., Jr., and LeRoith, D. (1994). Transcriptional repression of the insulin-like growth factor 1 receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.J. Biol. Chem. 269,12577-12582.
245. Werner, H., Shen-Orr, Z., Rauscher, F. J., Morris, J. F., Roberts, C. T., Jr., and LeRoith, D. (1995a). Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol. Cell. Biol. IS, 3516-3522.
246. Werner, H., Hernandez-Sanchez, C, Karnieli, E., and Leroith, D. (1995b). The regulation of the IGF-I receptor expression. Int. J. Biochem. Cell Biol. 27, 987-994.
247. Wilkins, M. R., and Needleman, P. (1992). Effect of pharmalogical manipulation of endogenous atriopeptin activity on renal function. Am. J. Pliysiol. 262, 161-167.
248. Williamson, K. A., and Van Heyningen, V. (1994). Towards an understanding of Wilms' tumour. Int. J. Exp. Palhol. 75, 147-155.
249. Wu, Y.-J., Fraizer, G. C, and Saunders, G. F. (1995). GATA-1 transactivates the WT1 hematopoietic specific enhancer. J. Biol. Chem. 270, 5944-5949.
250. Ye, Y., Raychaudhuri, B., Gurney, A., Campbell, C. E., and Williams, B. R. G. (1996). Regulation of WT1 by phosphorylation: Inhibition of DNA-binding, alteration of transcriptional activity and cellular translocation. EMBO J. 15, 5606-5615.
251. Ying, S.-Y. (1988). Inhibins, activins and follistatins: Gonadal proteins modulating the secretion of follicle stimulating hormone. Endocr. Rev. 9, 267-293.
252. Zhou, J., Rauscher, F. J., and Bondy, C. (1993). Wilms' tumor (WT1) gene expression in rat decidual differentiation. Differentiation 5, 109-114.
253. Zong, L., Sarafian, T., Kane, D. J., Charles, A. C, Mah, S. P., Edwards, R. H., and Bredesen, D. E. (1993). Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90, 4533-4537.